Ozempic, Wegovy Weight-Loss Drugmaker On Long-Term Effects скачать в хорошем качестве

Ozempic, Wegovy Weight-Loss Drugmaker On Long-Term Effects

#Ozempic #Wegovy #obesity #diabetes #weightloss #healthcare #pharmaceuticals #novonordisk #drugs #leadership #CEO Novo Nordisk’s blockbuster diabetes and obesity drugs, Ozempic and Wegovy, are revolutionizing the weight loss industry. Both contain the key ingredient, semaglutide - generating billions in sales. In some cases, patients might need to take the drugs indefinitely to avoid regaining much of the weight they lost. Speaking on Bloomberg’s Leaders With Lacqua, Novo Nordisk CEO Lars Fruergaard Jørgensen gives his personal views on the prospects of lifelong treatment and why the company will need to build a portfolio of interventions. Watch the full interview:    • The CEO Behind Ozempic, Wegovy and Europe'...   #bloomberg #leaderswithlacqua #francinelacqua -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9 Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on: X:   / bloombergtv   Facebook:   / bloombergtelevision   Instagram:   / bloombergtv   Connect with Bloomberg Business on: X:   / business   Facebook:   / bloombergbusiness   Instagram:   / bloombergbusiness   TikTok: https://www.tiktok.com/@bloombergbusi... Reddit:   / bloomberg   LinkedIn:   / bloomberg-news   More from Bloomberg: Bloomberg Radio:   / bloombergradio   Bloomberg Surveillance:   / bsurveillance   Bloomberg Politics:   / bpolitics   Bloomberg Originals:   / bbgoriginals   Watch more on YouTube: Bloomberg Technology:    / @bloombergtechnology   Bloomberg Originals:    / @business   Bloomberg Quicktake:    / @bloombergquicktake   Bloomberg Espanol:    / @bloomberg_espanol   Bloomberg Podcasts:    / @bloombergpodcasts